SCHEMBL4688221

SCHEMBL4688221

CCCCC(C)=CCO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4688217 1.00
SCHEMBL28564122 1.00
SCHEMBL8998810 0.92 MEN1 (0.50)
SCHEMBL8998816 0.92 MEN1 (0.50)
SCHEMBL10048632 0.92 MEN1 (0.50)
SCHEMBL29770496 0.91 KMT2A (0.65)
SCHEMBL8998633 0.90 MEN1 (0.48)
SCHEMBL4586773 0.90 MEN1 (0.48)
SCHEMBL22556624 0.90 MEN1 (0.48)
SCHEMBL8998668 0.90 MEN1 (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023006699-A1 CELLS AND METHOD FOR PRODUCING ISOPRENOID MOLECULES WITH CANONICAL AND NON-CANONICAL STRUCTURES Københavns Universitet (DK) 2023-02-02 WO disclosed
EP-2966054-B1 METHOD OF PRODUCING OPTICALLY-ACTIVE ALDEHYDE TAKASAGO PERFUMERY CO LTD (JP) 2019-01-02 EP disclosed
US-10029969-B2 Method of producing optically-active aldehyde TAKASAGO INTERNATIONAL CORPORATION (JP) 2018-07-24 US disclosed
EP-2966054-A1 METHOD OF PRODUCING OPTICALLY-ACTIVE ALDEHYDE Takasago International Corporation (JP) 2016-01-13 EP disclosed
US-20150376102-A1 METHOD OF PRODUCING OPTICALLY-ACTIVE ALDEHYDE TAKASAGO INTERNATIONAL CORPORATION (JP) 2015-12-31 US disclosed
EP-1603874-B1 G-LACTAM DERIVATIVES AS PROSTAGLANDIN AGONISTS SERONO LAB (CH) 2008-05-07 EP disclosed
EP-1603874-B1 G-LACTAM DERIVATIVES AS PROSTAGLANDIN AGONISTS SERONO LAB (CH) 2008-05-07 EP disclosed
US-7276531-B2 G-lactam derivatives as prostaglandin agonists APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2007-10-02 US disclosed
US-7276531-B2 G-lactam derivatives as prostaglandin agonists APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2007-10-02 US disclosed
US-7276531-B2 G-lactam derivatives as prostaglandin agonists APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2007-10-02 US disclosed
US-6184393-B1 MYXOPYRONINS AND CORALLOPYRONINS AS FURAN AND PYRAN- AND SMALL LACTONE-ANTIBIOTICS; INHIBITORS OF RNA POLYMERASE (RNAP) HAVING SELECTIVITY FOR HUMAN RNAP, CELL PENETRATION AND POTENCY AGAINST RIFAMPICIN-RESISTANT STAPH. AUREUS TRUSTEES OF BOSTON UNIVERSITY 2001-02-06 US disclosed
EP-0742211-B1 PYRIDAZINONE DERIVATIVES NISSAN CHEMICAL IND LTD (JP) 2000-05-10 EP disclosed
WO-2000015626-A1 PROCESS FOR THE PREPARATION OF INTERMEDIATES FOR PYRONIN ANTIBACTERIALS ANADYS PHARMACEUTICALS, INC. (US) 2000-03-23 WO disclosed
US-6022983-A PREPARING A MYXOPYRONIN SCRIPTGEN PHARMACEUTICALS, INC. (US) 2000-02-08 US disclosed
US-5856327-A INHIBITING PLATELET AGGREGATION NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 1999-01-05 US disclosed
US-5750523-A INHIBITING PLATELET AGGREGATION NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 1998-05-12 US disclosed
EP-0742211-A1 PYRIDAZINONE DERIVATIVE NISSAN CHEMICAL INDUSTRIES, LIMITED (JP) 1996-11-13 EP disclosed
EP-0258967-B2 Process for producing optically active alcohols TAKASAGO PERFUMERY CO LTD (JP) 1996-08-21 EP disclosed
US-4962242-A HYDROGENATING OLEFINIC ALCOHOL USING AS CATALYST A RUTHENIUM-OPTICALLY ACTIVE PHOSPHINE COMPLEX TAKASAGO PERFUMERY CO., LTD. (JP) 1990-10-09 US disclosed
EP-0258967-A2 Process for producing optically active alcohols Takasago Perfumery Co., Ltd. (JP) 1988-03-09 EP disclosed